Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer
Author:
Funder
Cancer Research UK
Kidani Memorial Fund
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
http://www.nature.com/articles/s41388-019-0780-z.pdf
Reference62 articles.
1. Yap TA, Workman P. Exploiting the cancer genome: strategies for the discovery and clinical development of targeted molecular therapeutics. Annu Rev Pharmacol Toxicol. 2012;52:549–73.
2. De Castro DG, Clarke PA, Al-Lazikani B, Workman P. Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance. Clin Pharmacol Ther. 2013;93:252–9.
3. Mancini M, Yarden Y. Mutational and network level mechanisms underlying resistance to anti-cancer kinase inhibitors. Semin Cell Dev Biol. 2016;50:164–76.
4. Garraway LA, Jänne PA. Circumventing cancer drug resistance in the era of personalized medicine circumventing cancer drug resistance in the era of personalized medicine. Cancer Discov. 2012;2:214–26.
5. Konieczkowski DJ, Johannessen CM, Garraway LA. A convergence-based framework for cancer drug resistance. Cancer Cell. 2018;33:801–15.
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Secosteroid diacylhydrazines as novel effective agents against hormone-dependent breast cancer cells;The Journal of Steroid Biochemistry and Molecular Biology;2024-11
2. Advances in the therapeutic study of oncolytic virus in colorectal cancer;Oncology and Translational Medicine;2024-07-02
3. B‐Cell Chronic Lymphocytic Leukemia and B‐Cell Lymphomas: The Key Role of Micro and Long Noncoding RNAs;Journal of Clinical Pharmacy and Therapeutics;2024-01
4. Differentially Expressed Genes (DEGs) Analysis Indicating 6-Shogaol Anticancer Activity Against HCT-116 Cells Performed Primarily by Affecting Genes in Common (SHARED-DEGs) of Apoptotic and P53 Signaling Pathways;Sains Malaysiana;2023-12-31
5. Secosteroid thiosemicarbazides and secosteroid–1,2,4-triazoles as antiproliferative agents targeting breast cancer cells: Synthesis and biological evaluation;The Journal of Steroid Biochemistry and Molecular Biology;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3